Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

The broad-spectrum antiemetic effects ETI-385 result from stimulation of 5-HT1A and 5-HT1D receptors.

Lucot JB, Brame RE, Garrett TL, Pfadenhauer EH, Kumar A, Fick DB, Helton DR.

Exp Brain Res. 2014 Aug;232(8):2699-707. doi: 10.1007/s00221-014-4004-z. Epub 2014 Jun 10.

PMID:
24913143
2.

Multicenter evaluation of automated immunoturbidimetric assays for measurement of apolipoproteins A-I and B in serum and plasma.

Kahn SE, Labbé RF, Pfadenhauer EH, Kanonchoff AD, Joseph RT.

Clin Chem. 1994 Sep;40(9):1722-9.

4.

Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.

Pfadenhauer EH, Bankert CS, Jensen J, Jones CE, Jenkins EE, McCloskey JA.

Drug Metab Dispos. 1984 May-Jun;12(3):280-4.

PMID:
6145553
5.
6.

Radioimmunoassay of the immunomodulator erythro-9-(2-hydroxy-3-nonyl)-hypoxanthine in human serum and urine.

Pfadenhauer EH, Jones CE, Maxwell KW.

J Pharm Sci. 1983 Aug;72(8):914-7.

PMID:
6620146
7.

Determination of inosine and adenosine in human plasma using high-performance liquid chromatography and a boronate affinity gel.

Pfadenhauer EH, Tong SD.

J Chromatogr. 1979 Apr 11;162(4):585-90. No abstract available.

PMID:
528669
8.

Rapid determination of some plasma oxypurines using high-pressure liquid chromatography.

Pfadenhauer EH.

J Chromatogr. 1973 Jun 27;81(1):85-92. No abstract available.

PMID:
4353497

Supplemental Content

Loading ...
Support Center